The prognostic relevance of p53 and Ki-67 to chemotherapy sensitivity and prognosis in triple-negative breast cancer.

Zhang, Guojing; Shi, Zhongyi; Liu, Lina; Yuan, Heqing; Pan, Zheng; Li, Wenxu; Tao, Yu; Huang, Zhaoming; Huang, Xiaoying; Lin, Chao

Zhang, Guojing; Shi, Zhongyi; Liu, Lina; Yuan, Heqing; Pan, Zheng; Li, Wenxu; Tao, Yu; Huang, Zhaoming; Huang, Xiaoying; Lin, Chao.

Afiliação

Zhang G; Oncology Department, Wenzhou Geriatric Hospital, Wenzhou, China.
Shi Z; Tumor Surgery Department, Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, China.
Liu L; Gynecology Department, Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, China.
Yuan H; Oncology Department, Wenzhou Geriatric Hospital, Wenzhou, China.
Pan Z; Oncology Department, Wenzhou Geriatric Hospital, Wenzhou, China.
Li W; Oncology Department, Wenzhou Geriatric Hospital, Wenzhou, China.
Tao Y; Oncology Department, Wenzhou Geriatric Hospital, Wenzhou, China.
Huang Z; Oncology Department, Wenzhou Geriatric Hospital, Wenzhou, China.
Huang X; Tumor Surgery Department, Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, China.
Lin C; Gynecology Department, Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, China.

Transl Cancer Res ; 10(2): 1082-1087, 2021 Feb.

Article em En | MEDLINE | ID: mdl-35116435

Palavras-chave

Ki-67; Triple-negative breast cancer (TNBC); chemotherapy sensitivity; p53; risk of recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Transl Cancer Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google